Exagen Inc

NASDAQ:XGN   4:00:00 PM EDT
2.70
-0.19 (-6.57%)
7:46:43 PM EDT: $2.59 -0.11 (-4.07%)
Other Pre-Announcement

Exagen Inc Reports Third Quarter 2022 Results

Published: 11/14/2022 21:41 GMT
Exagen Inc (XGN) - Q3 Revenue $14.7 Million.
Reports Third Quarter 2022 Results.
Qtrly Loss per Share $0.47.
Increasing Full Year 2022 Revenue Guidance, Range of $40 Million to $43 Million.
Number of Ordering Healthcare Providers Totaled 2,287 in Q3 of 2022.
Q3 Earnings per Share View $-0.73, Revenue View $9.1 Million -- Refinitiv Ibes Data (analyst estimates).
FY2022 Revenue View $38.1 Million -- Refinitiv Ibes Data (analyst estimates).